Tracking Biological Aging in Clinical Settings
AI Tool Predicts Cancer Survival via Face Photos
Mass General Brigham researchers develop FaceAge to track biological aging as a non-invasive prognostic biomarker.
A digital screen shows a human face scan with geometric data overlays used for biological age estimation in a medical research lab.
Photo: Avantgarde News
Researchers at Mass General Brigham introduced FaceAge, an artificial intelligence tool that calculates biological age using facial photographs [1]. The study demonstrates that monitoring how quickly a face ages over time can act as a non-invasive biomarker to predict survival outcomes for individuals with cancer [1][2]. This technology offers a potentially cost-effective way to assess patient health without invasive procedures [2].
The AI-driven system analyzes specific facial features to determine if a patient is aging faster than their chronological age [1]. While medical research often focuses on specific diseases like pancreatic cancer, tools like FaceAge look at broader systemic health indicators [3]. Scientists believe this prognostic tool could help clinicians tailor treatments based on a patient's biological resilience [1][2].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
- 1.↗
massgeneralbrigham.org
https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/faceage-tool-face-aging-rate-cancer-biomarker
- 2.↗
labcompare.com
https://www.labcompare.com/617-News/625406-AI-Tool-Uses-Face-Photos-to-Predict-Cancer-Outcomes/
- 3.↗
news-medical.net
https://www.news-medical.net/health/What-is-Pancreatic-Cancer.aspx
Related stories
View allTopics
About the author
Avantgarde News Desk covers tracking biological aging in clinical settings and editorial analysis for Avantgarde News.